Brief: 2cureX Gets Ethical Approval For HIPEC Clinical Trial

2cureX AB

06/12/2023 07:49

Dec 6 (Reuters) - 2cureX AB  2CUREX.ST :
    * 2CUREX RECEIVES ETHICAL APPROVAL FOR GROUNDBREAKING HIPEC
CLINICAL TRIAL
    * TO START  CLINICAL TRIAL USING INDITREAT IN HYPERTHERMIC
INTRAPERITONEAL CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER
PATIENTS

Source text for Eikon:  ID:nMFN8SgcrN 
Further company coverage:  2CUREX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))